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Abstract 
Several reports have shown the periventricular region of the brain, including the 
paraventricular nucleus (PVN) is critical to sensing and responding to changes in 
plasma osmolality.  Further studies also implicate the transient receptor potential 
ion channel, type V4 (TRPV4) channel in this homeostatic behaviour.  In previous 
work we show that TRPV4 ion channels couple to calcium activated potassium 
channels in the PVN to decrease action potential firing frequency in response to 
hypotonicity. In the present study we investigated whether, similarly, 
intracerebroventricular (ICV) application of hypotonic solutions modulated 
cardiovascular parameters, and if so whether this was dependent on the TRPV4 
channel.  
We found that ICV injection of 270mOsmol artificial cerebrospinal fluid (ACSF) 
decreased mean blood pressure, but not heart rate compared either to naïve mice 
or mice injected with 300mOsmol ACSF. This effect was abolished by treatment 
with the TRPV4 inhibitor RN1734.   
This data shows that periventricular targets within the brain are capable of 
generating depressor action in response to TRPV4 ion channel activation and raises 
the TRPV4 channel, or the TRPV4–KCa coupling mechanism as a potential 
therapeutic target for treatment of cardiovascular disease. 
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 Introduction 
Body fluid osmolality is usually regulated within an extremely narrow range (~290-
300 mosmol) (Bourque, 2008). This is largely maintained through regulation of renal 
function, but control areas exist both within and outside of the central nervous 
system (CNS). One important reason why animals have evolved to control 
osmolarity within the CNS is that osmoregulation is a complex process and needs to 
be integrated with other homeostatic elements.  Body systems defend electrolyte 
composition and osmolarity in parallel with blood pressure and blood volume 
(Share and Claybaugh, 1972).  In laboratory experiments each of these may be 
differentially regulated, but a healthy functioning animal each must be controlled as 
part of the overall pattern of homeostasis.  Within the brain, the area surrounding 
the third ventricle within the hypothalamus is particularly important for 
osmoregulation. Key areas identified to date include the subfornical (SFO), organum 
vasculosum lamina terminalis (OVLT), circumventricular organs (CVO), medial 
preoptic (MPO) area and paraventricular nucleus (PVN) of the hypothalamus 
(Stocker et al., 2007; Toney et al., 2003).  Our particular focus has been the PVN 
since this is an established autonomic control centre exerting influence over heart 
rate (HR) and blood pressure (BP) in response to a number of homeostatic 
challenges including temperature (Cham and Badoer, 2008), day-night cycle 
(Feetham and Barrett-Jolley, 2014), volume load (Lovick et al., 1993) and osmolarity  
(Stocker et al., 2004a).  The PVN is conveniently subdivided into two major areas; 
the parvocellular and magnocellular “sub-nuclei” (Swanson and Sawchenko, 1983).   
The magnocellular region would be a logical site of osmosensation since it contains 
a high density of neurones that secrete vasopressin (also known as anti-diuretic 
hormone, ADH) (Swanson and Sawchenko, 1983) from the neurohypophysis 
(posterior pituitary) which then exert profound effects on vascular contractility and 
on kidney water reabsorption as each of its two alternative names imply (Share, 
1988).  The parvocellular region of the PVN is named after the smaller 
“parvocellular” neurones within.  These neurones sub-serve diverse functions.  
Many release CRF into the hypophyseal portal circulation, which, in turn, evokes 
release of ACTH from the adenohypophysis (anterior pituitary) and is a key part of 
the ACTH-adrenal-cortisol axis (Antoni, 1993).  Additionally, the parvocellular region 
of the PVN also contains a number of neurones with autonomic control actions.  
These latter neurones project to areas such as the intermediolateralis (IML) of the 
spinal cord and synapse with preganglionic sympathetic neurones (Barrett-Jolley et 
al., 2000; Motawei et al., 1999; Pyner and Coote, 2000). When activated, these 
“pre-autonomic” neuroneselevate heart rate, blood pressure and sympathetic 
nerve activity (SNA) including renal SNA (rSNA) (Womack et al., 2007).  Some 
authors have alternatively concluded that the spinally projecting pre-autonomic 
PVN neurones are neither parvocellular, nor magnocellular, but a family of 
intermediately sized neurones they named mediocellular neurones with some merit 
(Kiss et al., 1991).  Under resting conditions  the pre-autonomic parvocellular 
neurones exist under a state of partially tonic inhibition by GABAergic input. 
Furthermore, application of the GABAA antagonist bicuculline evokes increases in 
rSNA, HR and BP (Chen et al., 2003). This tonic inhibition is not absolute, however, 
since paraventricular application of the GABAA agonist muscamol produces 
powerful inhibition of SNA with associated decreases of HR and BP (Zhang et al., 
2002), even in control rats.  Toney and colleagues, however, report that this 
response is more apparent in chronically dehydrated rats where the tonic inhibition 
of the PVN is reduced (Holbein et al., 2014; Stocker et al., 2004b).  This reduced 
tonic inactivity is due to an additional excitatory input from the MPO, rather than a 
demonstrable alleviation of the tonic GABA-ergic inhibition (Stocker and Toney, 
2005).  Thus, dehydration and hypertonicity (direct to hypothalamus or intra-
carotid) lead to elevated c-fos expression in pre-autonomic PVN neurones (Arnhold 
et al., 2007; Gottlieb et al., 2006; Stocker et al., 2004a) and increased spiking 
activity of hypothalamic neurones (Cross and Green, 1959), glutaminergic activity in 
medulla-projecting neurones (Stocker et al., 2006) and activity of vasopressin-ergic 
spinal neurones (Antunes et al., 2006).   
The true complexity of the whole-animal osmoregulation begins to emerge, 
however, when one also considers the cardiovascular responses to consumption of 
water.  Initially this would be expected to increase plasma volume and decrease 
plasma osmolality.  The response to water consumption in people is variable, 
however, depending on age and health status. In people with autonomic failure, 
consumption of moderate quantities of water evokes a substantial rise in blood 
pressure of up to 100mHg (Cariga and Mathias, 2001; Jordan et al., 1999; Lipp et al., 
2005).  This is absent in young healthy human subjects (Jordan et al., 2000). The 
detailed pattern of cardiovascular response to water consumption also includes 
increases in total peripheral resistance, presumably reflecting sympathetic 
vasomotor activity and decrease in heart rate despite very little overall change in 
blood pressure (Brown et al., 2005).  This decrease in heart rate results from an 
increase in cardiac vagal drive (Routledge et al., 2002).  Since these effects are seen 
with water, rather than oral consumption of isotonic saline (Lipp et al., 2005), 
plasma osmolality is clearly key. However, physiologically this may be an adaptation 
to rapidly redistribute plasma to the capacitance apparatus (Greenway and Lister, 
1974), rather than simply initiating diuresis.  From an evolutionary context this 
would make sense since animals tend to preserve water and ions where possible 
(Share and Claybaugh, 1972). It appears that in healthy animals, blood volume 
increase is opposed by increasing (sympathetically driven) vascular tone and blood 
pressure elevation is then limited by a vagal decrease in heart rate, this is more 
complex than a simple implementation of the baroreceptor reflex and whilst the 
site of such integrative control is not known, the hypothalamic PVN is well placed to 
contribute since it contains both sympathetic and vagal pre-autonomic neurones (Li 
et al., 2003).  The PVN has been shown to be critical to the sympathetic nerve 
response to isotonic volume expansion (Haselton et al., 1994), but not the 
baroceptor reflex, which is centred in the medulla (Spyer, 1994). There have been 
far fewer studies of hypotonic response than those to hypertonic exposure.  Intra-
carotid application of hypotonic solution shows decrease in SNA, and BP with HR 
increased (Brooks et al., 2005). However, these responses were seen only in water-
deprived animals and little response was seen in euhydrated rats.  The early studies 
of Cross and Green (Cross and Green, 1959) showed a correspondingly limited 
suppression of action potential activity in the hypothalamus following intra-carotid 
hypotonic saline.  In our own ex vivo “brain-slice” work, we found that a proportion 
of parvocellular neurones did respond to direct application of hypotonic solutions 
(Feetham et al., 2014).  This would certainly have been expected for magnocellular 
neurones, which would be expected to switch off vasopressin release and thus 
increase diuresis, but was unexpected in parvocellular neurones. In our ex vivo work 
we established that TRPV4 was a critical element in this osmosensing and this is 
very much what would be expected from the observations that TRPV4 is expressed 
in the PVN (Carreno et al., 2009) and that TRPV4-/-knock-out leads to animals unable 
to detect hypo-osmolarity and respond with diuresis (Liedtke and Friedman, 2003; 
Mizuno et al., 2003). 
In the current work therefore, we investigated simply whether direct intra-
cerebroventricular application of hypotonic saline to normal rats modulated their 
cardiovascular system, and if so whether this response was sensitive to the TRPV4 
antagonist RN1734. 
  
Methods 
 
Ethics approval 
All animal work (CD1 mice) was carried out in accordance with the UK Animals 
(Scientific Procedures) Act 1986. All use of animals and animal tissue was authorised 
by UK Home Office licence. All surgery was performed under anaesthesia as 
described in detail below. 
 
Immunohistochemistry  
Immunohistochemistry was performed using a rabbit primary antibody for TRPV4 
(1:300; Abcam, UK), and goat secondary antibody anti rabbit CY3 (1:300; Abcam, 
UK). Blue DAPI dye was applied as a nuclear counter-stain, using VECTASHIELD 
mounting medium with DAPI (Vector laboratories, UK). Negative controls involved 
primary antibody omission. 
Cannulation 
Adult CD1 wild-type male mice (30-40g) and were anaesthetised with a combination 
of urethane and α-chloralose (Sigma-Aldrich, UK), administered at an appropriate 
dose IP in saline. Urethane was used to minimise the effects on the cardiovascular 
system (Carruba et al., 1987). Following injection of the anaesthetic, the mice were 
returned to their cage for several minutes until they lost consciousness. Body 
temperature was recorded immediately and continuously by rectal probe and 
maintained at 37±0.5 °C by use of a heat lamp. Once loss of paw-withdrawal and 
eye-blink reflexes was achieved the trachea was intubated in order to maintain 
respiration. The carotid artery was cannulated with stretched PE25 tubing filled 
with heparinised saline. Blood pressure was recorded by a pressure transducer 
attached to the tubing and connected to a Neurolog (Digitimer Ltd, Herefordshire, 
UK) blood pressure amplifier. BP signals were digitised to PC with a CED Micro1401 
(Cambridge Electronic Design, Cambridge, UK) using WinEDR at 5 kHz.  
Heart rate measurement 
Heartbeats were annotated to the amplified AC coupled blood pressure signal using 
Wabp from the PhysioNet suite of programs to give heart rate of the animals 
(Goldberger et al., 2000).  Briefly, the signal was analysed at 1/10th sampling 
frequency (ie. 500 Hz), and resampled to 125 Hz for optimal beat detection by 
Wabp. Annotated beats were then reverted to 10 times speed to give the actual 
heart rate. 
Intracerebroventricular injections 
For intracerebroventricular (ICV) injections the anaesthetised mice were placed in a 
stereotaxic frame adapted for mice (Kopf instruments).  Their heads were clamped 
gently and held in a level position and the skull was exposed. Bregma was located at 
coordinates 3.8 ± 0.3mm rostral and 5.8± 0.5mm dorsal to intraural line taken from 
the Paxinos and Franklin adult mouse stereotaxic atlas (Paxinos and Franklin, 2001); 
a 2mm craniotomy, 1mm lateral and 0.2mm caudal to Bregma allowed for drug or 
vehicle to be applied via 10μL Hamilton syringe. All drugs were given in ACSF as the 
vehicle, and injected in a 1µl volume gradually over a 30 second period. All 
injections were given into the lateral ventricle at the following coordinates; 0.2mm 
caudal, 1mm lateral, 3.2mm vertical. The syringe was left at the injection site for 2 
minutes and elevated to just above the injection site after this time, where it was 
kept in place for the duration of the recording.  At the end of the procedure all 
animals were injected with 1% pontamine blue dye (Sigma-Aldrich, UK) at the same 
injection site using the same volume in order to confirm the correct location for the 
injection site.  Post mortem, the brain removed and sliced to 300μm on a Campden 
Instruments Ltd 752 M Vibroslice to locate the injection site.  
Drug injections 
Drugs/ vehicle controls used were; 1μL isotonic/isotonic+DMSO ACSF, hypotonic 
ACSF (~280 mosmol) and RN1734 (Tocris, UK) in vehicle (ACSF) (100nmol/kg). 
Results 
It has been suggested TRPV4 may be responsible for volume control centrally 
(Bourque, 2008).Therefore we began by verifying the presence of the TRPV4 ion 
channel within the PVN with immunohistochemistry.  We detected clear 
immunoreactivity to the TRPV4 channel within the parvocellular subnucleus of the 
PVN (Figure 1).  Next, we investigate whether simple ICV injection had a 
confounding effect on cardiovascular parameters.  In mice injected ICV with isotonic 
ACSF plus DMSO 0.01% (~300 mosmol) neither BP nor HR were significantly 
changed (Figure 2 and Figure 5 n=6; p>0.05 by ANOVA using Tukey’s post hoc 
comparison).  Next, ICV injections of 1µl ~270 mosmol ACSF were given to 
investigate the central effects of hypo-osmolality on cardiovascular parameters.  
Hypotonic ACSF administered centrally resulted in a significant decrease in mean 
arterial pressure of -9 ± 2 mmHg (n=6; p<0.01 by ANOVA using Tukey’s post hoc 
comparison).  No change in heart rate was observed (Figure 2 and Figure 5; n=6; 
p>0.05 by ANOVA; Figure 3).  Reduction in BP upon hypotonic injection was also 
significant compared to control (isotonic) ICV ACSF injection (Figure 5; -9 ± 2 mmHg 
vs -2 ± 1 mmHg; n=6; p<0.01 by ANOVA with Tukey’s post hoc comparison).  
Finally, we investigated whether the depressor action of hypotonic solution was 
dependent on TRPV4 channels.  We tested this using 100 nM/kg of the selective 
TRPV4 inhibitor RN1734 (Vincent et al., 2009) along with hypotonic ASCF was 
injected ICV into anaesthetised mice.  Addition of the TRPV4 inhibitor prevented the 
reduction in mean arterial pressure observed with injection of hypotonic ACSF alone 
(Figure 4 and Figure 5; n=6; p>0.05 by ANOVA using Tukey’s post hoc comparison).  
Again, no difference in heart rate was observed (Figure 4 and Figure 5; n=6; p>0.05 
by ANOVA using Tukey’s post hoc comparison). 
Discussion 
In this study we identify a clear depressor action of euhydrated CD1 mice 
challenged with ICV hypotonic solution.  This effect was prevented by treatment 
with the TRPV4 antagonist RN1734. 
Several studies have indicated that the periventricular region of the brain is key to 
detecting and responding to osmotic challenge (Stocker et al., 2007; Toney et al., 
2003), and our own work has demonstrated that, in vitro, PVN neurons can detect 
and respond to hypotonic solutions with a decrease in action potential firing 
(Feetham et al., 2014).  In vivo the complex homeostatic response to PVN challenge 
with osmotic stimuli is likely to include both vasopressin release and activity of 
spinally projecting neurones; including interactions between these two pathways 
via dendritic-dendritic signalling (Stern, 2014).   
Our previous report analysed this coupling in fine detail and found that TRPV4 
channels initially allow Ca2+ entry which in turn activates potassium channels and 
subsequently inhibits the firing of action potentials (Feetham et al., 2014).  This 
effect is consistent with previous reports that the TRPV4 channel is known to be 
activated by osmolality changes (Liedtke et al., 2000) and has a role in volume 
control in other tissues (Becker et al., 2005; Benfenati et al., 2011; Guilak et al., 
2010).  Our combination of isolated neuron and brain slice experiments suggested 
that this is a direct effect within PVN parvocellular neurons rather than an indirect 
modulation of PVN projecting neurons. The latter, however, remains a possibility 
since spinally projecting PVN neurons receive functional inputs from a number of 
other hypothalamic nuclei (Cui et al., 2001; Stocker and Toney, 2005; Womack and 
Barrett-Jolley, 2007).  This region of the PVN includes spinally projecting neurons 
which positively modulate the cardiovascular system (Coote, 2007) and so we 
hypothesised that such inhibition may result in a depressor action and reduction in 
HR.  In the present study we find that whilst ICV hypotonic solutions do reduce BP, 
they have little effect on heart rate.  Furthermore, the nature of this injection site 
means that it is not possible to know if the target neurons are in the PVN or some 
other peri-ventricular site.  It is clear however that this effect involves TRPV4 
channels, since the selective inhibitor RN1734 (Vincent et al., 2009) abolished the 
effect.  It is also important to note that it was necessary to conduct this study in 
anaesthetised animals, which may have affected the response to hypotonicity.  
Anaesthetics do affect the cardiovascular system; for example, by reducing resting 
BP which is quite low in this study compared to what one may expect in a conscious 
animal study, but in line to that recorded previously for wildtype mice (Nunn et al., 
2013).   
These data support previous reports that changes in central osmolality results in the 
modulation of blood pressure (Brooks et al., 2005; Scrogin et al., 1999).  In previous 
studies altered heart rate has also been recorded upon osmotic change (Chen and 
Toney, 2001); however, our results show no statistically significant differences. This 
is not completely unexpected due to the baroreceptor reflex, which would be 
working to counteract the reduction in blood pressure (Spyer, 1994).   Together, this 
and our previous data strongly support the notion that there is a role for central 
TRPV4 channels in sensing osmolality changes and initiating changes in blood 
pressure.  Although the exact position of these channels centrally is unknown, they 
could be within the PVN itself. Further, perhaps identified spinally projecting 
neurone work, will be required to establish this.  
Potentially, pharmacological modulation of blood pressure via TRPV4 channels 
could be useful in the treatment of cardiovascular disease; however, the 
widespread distribution of these ion channels could limit their practical usefulness.  
Therefore future studies will be aimed at identifying the receptor and 
neurotransmitter profile of PVN osmosensing neurones to determine if we can 
identify more specific therapeutic targets. 
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ACSF  artificial cerebrospinal fluid 
ACTH  adrenocorticotropic hormone 
Ang II  angiotensin II 
CRF  corticrotrophin releasing factor  
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ICV  intracerebroventricular 
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PVN  paraventricular nucleus 
RSNA  renal sympathetic nervous activity 
SCN  suprachiastmatic nucleus 
SFO  subfornical organ 
SNA  sympathetic nervous activity 
SNS  sympathetic nervous system 
TRP  transient receptor potential 
TRPV  transient receptor potential vanilloid  
  
Figure Legends 
Figure 1. Immunofluorescent identification of TRPV4 in the paraventricular 
nucleus.  
Rat PVN coronal slice labelled with antibody to TRPV4. (A) Negative control showing 
DAPI blue, with the absence of red TRPV4 staining (B) Red staining is positive for the 
TRPV4 channel, blue is DAPI nuclei staining. Scale bar 100µm and 3V indicates the 
3rd ventricle. (C) High magnification images of a section seen in (B).  Red staining is 
TRPV4 and blue is DAPI nuclei staining; arrows indicate where overlap can be seen.  
Scale bar is 25 µm. 
 
Figure 2. Intracerebroventricular injection of isotonic ASCF has no effect on 
cardiovascular parameters.  
Adult male CD1 mice were anaesthetised with urethane-chloralose, and blood 
pressure was recorded by cannulation of the carotid artery.  (A) Raw blood pressure 
trace with annotated beats (purple lines), before (i) and after (ii) injection of 
300mOsm ACSF/DMSO vehicle.  Annotated beats are used to derive R-R interval 
and heart rate. (B) Example R-R interval trace shows no difference before (i) and 
after (ii) ICV injection of isotonic ACSF. (C) Example heart rate trace shows no 
difference before (i) and after (ii) injection of isotonic ACSF.  (D) Average blood 
pressure and (E) heart rate do not change with injection of isotonic vehicle (n=6; 
p>0.05). 
 
Figure 3. Intracerebroventricular injection of hypotonic ASCF decreases blood 
pressure but has no effect on heart rate.  
Blood pressure significantly decreases after injection of hypotonic ACSF. (A) Raw 
blood pressure trace with annotated beats (purple lines), before (i) and after (ii) 
injection.  Annotated beats are used to derive R-R interval and heart rate. (B) 
Example R-R interval trace shows no difference before (i) and after (ii) ICV injection 
of hypotonic ACSF. (C) Example heart rate trace shows no difference before (i) and 
after (ii) injection of hypotonic ACSF.  (D) Average blood pressure is significantly 
reduced with injection of hypotonic ASCF (n=6; *p<0.01), but heart rate (E) remains 
unchanged (p>0.05). 
 
Figure 4. Intracerebroventricular injection of the TRPV4 inhibitor RN1734 prevents 
the effect of hypotonic ACSF on blood pressure.  
(A) Raw blood pressure trace with annotated beats (purple lines), before (i) and 
after (ii) injection.  Annotated beats are used to derive R-R interval and heart rate. 
(B) Example R-R interval trace shows no difference before (i) and after (ii) ICV 
injection. (C) Example heart rate trace shows no difference before (i) and after (ii) 
ICV injection.  (D) Average blood pressure response to hypotonic ASCF is prevented 
by injection of RN1734 (n=6; p>0.05).  (E) Average heart rate remains unchanged 
(n=6; p>0.05). 
Figure 5.  Summary average changes in cardiovascular parameters from ICV 
injections.   
(A) Average change in blood pressure compared to control of several ICV injection 
treatments.  No significant change was seen with vehicle (isotonic ACSF) or the 
TRPV4 inhibitor, RN1734 (100 nM/kg) alone vs control (n=6; p>0.05).  Blood 
pressure is significantly reduced in animals injected with hypotonic ACSF compared 
to those injected with vehicle (n=6; *p<0.01).  ICV injections with RN1743 + 
hypotonic ACSF did not produce a significant blood pressure change compared to 
vehicle injections (n=6; p>0.05), but blood pressure change was significantly 
reduced compared to hypotonic injections (n=6; #p<0.01).  (B)  Average heart rate 
did not change significantly between any of the conditions stated (n=6; p>0.05 by 
ANOVA). 
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